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ABSTRACT
Motivation: Since susceptibility to diseases increases with age,
studying aging gains importance. Analyses of gene expression or
sequence data, which have been indispensable for investigating
aging, have been limited to studying genes and their protein products
in isolation, ignoring their connectivities. However, proteins function
by interacting with other proteins, and this is exactly what biological
networks (BNs) model. Thus, analyzing the proteins’ BN topologies
could contribute to understanding of aging. Current methods for
analyzing systems-level BNs deal with their static representations,
even though cells are dynamic. For this reason, and because
different data types can give complementary biological insights, we
integrate current static BNs with aging-related gene expression data
to construct dynamic, age-specific BNs. Then, we apply sensitive
measures of topology to the dynamic BNs to study cellular changes
with age.
Results: While global BN topologies do not significantly change with
age, local topologies of a number of genes do. We predict such genes
as aging-related. We demonstrate credibility of our predictions by:
1) observing significant overlap between our predicted aging-related
genes and “ground truth” aging-related genes; 2) showing that our
aging-related predictions group by functions and diseases that are
different than functions and diseases of genes that are not predicted
as aging-related; 3) observing significant overlap between functions
and diseases that are enriched in our aging-related predictions and
those that are enriched in “ground truth” aging-related data; 4)
providing evidence that diseases which are enriched in our aging-
related predictions are linked to human aging; and 5) validating all of
our high-scoring novel predictions via manual literature search.
Contact: tmilenko@nd.edu
1 INTRODUCTION
1.1 Motivation and background
Since the US is on average growing older because of ∼78 million
of baby boomers who have began turning 65 in 2011, and since
susceptibility to diseases increases with age, studying human aging
gains importance. Analysis of gene expression data has been
indispensable for investigating aging (Wieser et al., 2011; Fortney
et al., 2010). However, it has mostly been limited to studying
differential expression of individual genes, without considering
their connectivities (Fortney et al., 2010). But, it is the proteins
(gene products) that carry out cellular processes and they do
so by interacting with other proteins instead of acting alone.
And this is exactly what biological networks and protein-protein
interaction (PPI) networks in particular model; in PPI networks,
nodes are proteins and edges correspond to physical interactions
between the proteins. Thus, analyzing topologies of proteins in
∗To whom correspondence should be addressed
PPI networks could contribute to understanding of the processes of
aging. Although as a proof of concept this study focuses on PPI
networks, it is applicable to other types of biological networks.
High-throughput screens for PPI detection have yielded systems-
level (though incomplete) PPI networks for many organisms, which
are publicly available (Breitkreutz et al., 2008).
The majority of current methods for analyzing systems-level PPI
networks deal with their static representations, due to limitations
of biotechnologies for PPI data collection, even though cells are
dynamic (Przytycka and Kim, 2010). For this reason, and because
different data types can give complementary biological insights
(Memisˇevic´ et al., 2010; Przytycka and Kim, 2010), we integrate
current static PPI network data (Peri et al., 2004; Breitkreutz et al.,
2008) with age-specific gene expression data (Lu et al., 2004) to
computationally construct dynamic, age-specific PPI networks, in
order to study cellular changes with age from such networks.
Furthermore, topological positions of aging-related genes in the
static networks have been studied (Kriete et al., 2011; Ferrarini
et al., 2005; Reja et al., 2009; Promislow, 2004; de Magalha˜es,
2009), but mostly with crude measures of topology that can
not cope with the complexity of PPI networks (Przˇulj, 2011).
For example, node degrees have been used to argue the central
role or aging-related proteins in the yeast network compared to
proteins that are not associated with aging, or to study the role
of chaperones (heat stock proteins) in aging (Promislow, 2004;
So˝ti and Csermely, 2007). In addition to aging, many approaches
have aimed to link node degrees with, for example, essentiality
(Jeong et al., 2001), disease (Sharan and Ideker, 2008; Vanunu
et al., 2010), cancer (Jonsson and Bates, 2006; Aragues et al.,
2008), or pathogenicity (Dyer et al., 2008). However, it is possible
that the high-degree proteins have been more studied simply
because of their known relevance to human health (Przˇulj, 2011;
Ratmann et al., 2009). Hence, more constraining measures of
topology might be needed that go beyond capturing only the direct
network neighborhood of a node (Milenkovic´ and Przˇulj, 2008;
Milenkovic´ et al., 2010a). While such measures exist and have been
used to link proteins’ network positions with their involvement in
some biological processes (Sharan et al., 2007; Milenkovic´ et al.,
2011), to our knowledge, they have not been linked to proteins’
involvement in aging even in static and especially in dynamic
PPI networks. Here, we apply a series of measures of topology,
including some highly sensitive measures (Milenkovic´ and Przˇulj,
2008; Milenkovic´ et al., 2011), to the dynamic PPI networks to
identify key players in aging.
1.2 Our study
We aim to study human aging via integration of aging-related
gene expression data with static PPI network data (Fig. 1). We
obtain dynamic, age-specific PPI networks by selecting in the static
network: 1) all proteins that correspond to actively expressed genes
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Fig. 1. Summary of our study. We
integrate a static PPI network with
aging-related gene expression data
to obtain age-specific networks. We
analyze changes in global and local
network topologies with age. While
global network analysis indicates no
age-specific change, local topologies
(as captured by seven node centrality
measures) of some proteins do
significantly change with age. We
predict such proteins as aging-
related and validate our predictions
in several ways.
at different ages and 2) all PPIs involving these “active” proteins.
Hence, each age-specific network is the network that is “active”
at a given age. We hypothesize that the dynamic and integrative
network analysis provides a valuable model of cellular functioning
that can reveal aging-related information and that can reveal more
of the information than static analysis of individual data types.
Given the dynamic network data, we first aim to answer whether
the overall network topologies change with age (Fig. 1). Since this
is not the case, and since the gene expression data alone revealed
only a small portion of all genes as aging-related (Lu et al., 2004), it
could be that local topologies around only a subset of proteins in the
network do change with age. Hence, we study positions of proteins
in each age-specific PPI network with respect to measures of local
topology, called node centralities, with the goal of identifying
proteins whose centralities significantly change with age. We find
515 such proteins (8.1% of all proteins in the static network), which
is quantitatively consistent to the result by Lu et al. (2004). We
predict these proteins as aging-related and validate them as follows.
1) The predictions are statistically significant, i.e., non-random.
2) The overlap of our predicted aging-related genes and “ground
truth” aging-related genes is significant. All of our five highest-
scoring predictions, namely GORASP2, MAP2K4, TIAM1,
MAP1B, and S100B, are present in multiple aging-related “ground
truth” data sets. Nonetheless, many of our predictions are novel, i.e.,
absent from the “ground truth” data. This confirms that dynamic
network analysis of integrated data types can reveal additional
biological knowledge compared to static analysis of individual data.
3) Our predictions group by biological functions and diseases that
are different than functions and diseases of genes that we do not
predict as aging-related. The overlap between functions and diseases
that are enriched in our predictions and those that are enriched in the
“ground truth” aging-related data is significant. Diseases that are
enriched in our predictions are linked to human aging.
4) We manually search in the literature for our top 10% highest-
scoring predictions that are not present in the “ground truth” aging-
related data, and we successfully validate all of them.
2 MATERIALS AND METHODS
2.1 Data
2.1.1 Aging-related gene expression data We use human brain gene
expression data consisting of 30 samples obtained from 30 individuals
between 26 and 106 years of age. In an individual, Lu et al. (2004) defined
a gene as being expressed (or active) at a given age if its detection p-value,
which indicates the significance level of its mRNA abundance at that age, is
less than 0.04. We adopt the same procedure (Supplementary Section S1.1).
2.1.2 Static PPI network data We obtain human static PPIs from
HPRD (Peri et al., 2004) and BioGRID (Breitkreutz et al., 2008). HPRD
data consists of 9,322 unique proteins and 36,030 unique PPIs between the
proteins. BioGRID data consists of 10,078 unique proteins (with respect to
their gene IDs) and 50,954 unique PPIs between the proteins.
2.1.3 Integrating static PPI network with gene expression data
to form age-specific PPI networks We form dynamic, age-specific
networks as follows. To form the network specific to a given age, we
select in the static network those proteins that are expressed at that age
(Section 2.1.1) and all PPIs that exist between the expressed proteins (see
Supplementary Section S1.2 for a formal description). Since gene expression
data is collected for 30 ages, 30 age-specific networks can be formed from
the given static network. Since we study two static networks (HPRD and
BioGRID), we obtain two sets of dynamic networks. We run subsequent
analyses on each of the network sets. Since we find that results are similar
across the two sets, for simplicity, here we report results only for the HPRD
network. Results for the BioGRID network are reported in the Supplement.
2.1.4 “Ground truth” aging-related data We denote the set of
genes present in both the static PPI network (Section 2.1.2) and brain gene
expression data (Section 2.1.1) as StatNetExpression.
By studying brain gene expression data from Section 2.1.1, Lu
et al. (2004) predicted 442 genes as aging-related, as their expression
significantly correlated with age. Of these, 341 genes are present in
StatNetExpression. Henceforth, we denote this “ground truth” aging-related
set of 341 genes predicted from brain gene expression data alone as
BrainExpression2004Age.
By studying another brain gene expression data with 174 samples
from 55 individuals, with multiple sample per individual, Berchtold
et al. (2008) identified 8,277 genes (via 12,514 probes) whose expression
significantly changed with age. Of these, 3,228 are present in
StatNetExpression. Henceforth, we denote this “ground truth” aging-related
set of 3,228 genes predicted from brain gene expression data alone as
BrainExpression2008Age.
Clearly, BrainExpression2004Age and BrainExpression2008Age are very
similar in the sense that their aging-related genes have been inferred from
brain gene expression data. (And as such, among all “ground truth” data
sets (see below), these two sets are expected to be the most similar to
our aging-related predictions, since our predictions are also partly based
on brain human gene expression data.) However, it is important to note
that BrainExpression2004Age and BrainExpression2008Age were predicted
from two independent data sets, and compared to BrainExpression2004Age,
BrainExpression2008Age is a result of a newer microarray study, it covers
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more samples and more individuals, and it covers more samples per
individual.
By studying brain gene expression data set related to different stages
of Alzheimer’s disease (AD), Simpson et al. (2011) identified 2,911 genes
(linked to 3,404 probes) that have significantly different expression levels
at different stages of AD. Of these, 1,117 are present in StatNetExpression.
Henceforth, we denote this “ground truth” AD-related set of 1,117 genes
predicted from brain gene expression data as ADExpressionAge.
By studying gene expression data related to Hutchinson-Gilfold progeria
syndrome (HGPS), a human premature aging-related disease, Liu et al.
(2011) identified 1,731 genes that have a differentially methylated region
between wild-type and HGPS-affected fibroblasts of vascular muscles cells.
Of these, 708 are present in StatNetExpression. Henceforth, we denote
this “ground truth” HGPS-related set of 708 genes predicted from vascular
muscles-related gene expression data as HGPSExpressionAge.
In July 2012, GenAge contained 261 human genes that have been linked
to aging as sequence-based orthologs of aging-related genes in model species
(de Magalha˜es et al., 2009). Of these, 230 are present in StatNetExpression.
Henceforth, we denote this “ground truth” aging-related set of 230 genes
predicted from sequence data by SequenceAge.
2.1.5 Complements of the “ground truth” aging-related data We
define a set of genes as the complement of a “ground truth” aging-related
data set if the genes are present in StatNetExpression but not in the “ground
truth” data set. We denote the complements of BrainExpression2004Age,
BrainExpression2008Age, ADExpressionAge, HGPSExpressionAge, and
SequenceAge as BrainExpression2004Complement, BrainExpression2008Complement,
ADExpressionComplement, HGPSExpressionComplement, and SequenceComplement,
respectively.
All above data sets are defined with respect to HPRD PPI data. For
BioGRID data, see Supplementary Section S1.3.
2.2 Do global network topologies change with age?
Given the dynamic, age-specific PPI networks, we test whether the overall
(global) topologies of the networks change with age. We do so by comparing
the different networks with respect to several commonly used global network
properties (Section 2.2.1), by evaluating the fit of each of the age-specific
networks to a series of well-known graph families, i.e., network models
(Section 2.2.2) (Milenkovic´ et al., 2008; Kuchaiev et al., 2011), and by
measuring the overlap of the age-specific networks (Section 2.2.3).
2.2.1 Comparing global properties of age-specific networks We
analyze three properties: the average clustering coefficient, average diameter,
and graphlet frequency distribution (Memisevic´ et al., 2010). The properties
are defined in Supplementary Section S1.4.
2.2.2 Evaluating the fit of age-specific networks to different graph
families or network models We compare the fit of the dynamic PPI
networks to different graph families, i.e., network models (Milenkovic´ et al.,
2009), to test whether the best fitting model changes with age. Various
network models have been proposed. We use: (1) Erdo¨s-Re´nyi random
graphs (ER), (2) generalized Erdo¨s-Re´nyi random graphs with same degree
distribution as the data (ERDD), (3) geometric random graphs (GEO), (4)
geometric gene duplication and mutation model (GEOGD), (5) scale-free
networks (SF), and (6) scale-free gene duplication and mutation model
(SFGD) (Milenkovic´ et al., 2008; Kuchaiev et al., 2011). To evaluate the
fit of the data network to a given model, we compare the topology of the
data network to the topology of a random network instance drawn from the
model with respect to a highly constraining measure of network topological
similarity called graphlet degree distribution agreement (GDD-agreement)
(Przˇulj, 2007). For details, see Supplementary Section S1.5.
2.2.3 Computing the overlap between age-specific networks We
measure the overlap between each pair of age-specific networks as the
percentage of nodes (or edges) in the smaller of the two networks that are
common to the two networks. For details, see Supplementary Section S1.6.
2.3 Do local topologies of proteins change with age?
We study topological positions of proteins in each age-specific network with
respect to seven node centrality measures (Section 2.3.1). We predict as
aging-related those proteins whose centralities significantly change with age
(Section 2.3.2). We validate our predictions in several ways (Section 2.3.3).
2.3.1 Local measures of topology or node centralities Various
centrality measures have been used to link topological importance of a node
in the network to its functional importance. Below, we define each of the
seven measures that we use and provide biological justification for their use.
Degree centrality (DEGC) measures the degree of a node in the network,
i.e., the number of the node’s neighbors. The higher the degree of a node,
the more central the node according to DEGC. Since current PPI networks
have “power-law” degree distributions, with many low-degree nodes and few
high-degree nodes, and since removal of the high-degree nodes would impact
the network structure (by disconnecting it), DEGC of a gene has been related
to the gene’s essentiality as well as its involvement in disease (Baraba´si and
Oltvai, 2004; Sharan and Ideker, 2008).
Clustering coefficient centrality (CLUSC) measures, for a given node,
how many pairs of neighbors of the node are connected by an edge, out
of all pairs of the node’s neighbors. Intuitively, the more interconnected the
neighborhood of the node, the more central the node is according to CLUSC.
In a PPI network, a node with high clustering coefficient, together with the
node’s neighbors, forms a highly interconnected network region, which is
likely to correspond to a functional module (Baraba´si and Oltvai, 2004).
K-core of a network is a maximal subset of nodes in the network such
that each node is connected to at least k others in the subset. K-coreness
centrality (KC) of a node is k if the node is in k-core. Nodes with high KC in
the human PPI network have been found to correspond to “core diseaseome,”
a subnetwork that is significantly enriched in disease genes and drug targets
(Janjic´ and Przˇulj, 2012), as well as to influential “spreaders” of information
throughout the network (Kitsak et al., 2010).
Graphlet degree centrality (GDC) measures how many graphlets a
node participates in, for all 2-5-node graphlets (Milenkovic´ et al., 2011).
Intuitively, the more graphlets a node touches, the more central the node
is according to GDC. Since it captures the extended network neighborhood
of a node, GDC is a highly sensitive measure of network topology. Thus,
in a PPI network, proteins with high GDCs represent potential candidates
for therapeutic intervention, since targeting such proteins with drugs would
have more significant impact on the network structure than targeting proteins
that reside in sparse and non-complex network regions (Milenkovic´ et al.,
2011). Indeed, GDC has been found to capture well disease and pathogen-
interacting proteins and drug targets (Milenkovic´ et al., 2011).
Betweenness centrality (BETWC) measures the involvement of a node
in the shortest paths in the network. Intuitively, nodes that occur in many
shortest paths have high centrality according to BETWC. BETWC of node v,
Cbetwc(v), is: Cbetwc(v) =
∑
s6=v 6=t∈V
σst(v)
σst
, where V is the set of nodes
in the network, σst is the number of shortest paths between nodes s and t,
and σst(v) is the number of shortest paths between s and t that go through
v. In a PPI network, BETWC of a protein indicates the “likelihood” of the
protein to participate in pathways connecting all other proteins (Koschu¨tzki
and Schreiber, 2008). Removal of a protein that is on critical pathways
between many other proteins could cause loss of communication between
the proteins. Also, targeting such a node with a drug could cause the drug
effects to spread fast to all the nodes (Milenkovic´ et al., 2011). This property
has been used to identify gene-disease associations by encoding each gene
in the network based on the distribution of shortest path lengths to all genes
associated with disease (Radivojac et al., 2008). Also, see Kitsak et al.
(2010).
Closeness centrality (CLOSEC) measures the “closeness” of a node to
all other nodes in the network. Intuitively, nodes with small shortest path
distances to all other nodes have high centrality according to CLOSEC.
CLOSEC of node v, Cclosec(v), is: Cclosec(v) = 1∑
u∈V
σ(u,v)
, where
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σ(u, v) is the shortest path distance between nodes u and v. In a PPI
network, CLOSEC of a protein indicates the “likelihood” of the protein to
reach or be reachable from all other proteins (Scardoni et al., 2009). And it
has been a widely accepted assumption that proteins that are closer to each
other are more likely to perform the same function (Sharan et al., 2007).
Eccentricity centrality (ECC) is very related to CLOSEC, except that it
measures the “closeness” of a node only to the farthest node in the network
(Wuchty and Stadler, 2003). Intuitively, nodes with small shortest path
distances to the furthest node in the network have high centrality according
to ECC. ECC of node v, Cecc(v), is: Cecc(v) = 1maxu∈V {σ(u,v)} .
2.3.2 Prediction of aging-related genes For each measure, we
compute centrality values for a node in each of the 30 age-specific networks.
Then, we calculate Pearson or Spearman correlation between the 30 ages
and the node’s 30 centrality values (Supplementary Section S1.7). We do
this for all genes that are expressed in at least five ages in Lu et al. (2004)’s
brain gene expression data (Section 2.1.1). If such a gene is unexpressed
at a given age, we assign it a centrality value of zero at that age. Since
results are consistent for both correlation measures, here we report results
only for Pearson correlation. Results for Spearman correlation are shown in
the Supplement.
We quantify the statistical significance of the given correlation value by
measuring the probability (i.e., p-value) of observing by chance a better
value (i.e., the same or higher value when the original value is positive, or
the same or lower value when the original value is negative). We do this
by randomly reshuffling the 30 node centrality values at the 30 ages and by
computing the resulting “random correlation”. We repeat this 1,000 times to
get 1,000 random correlations. We compute the p-value as the percentage
of the 1,000 runs in which the random correlation is better than the original
one. We predict a gene as aging-related if its p-value is below 0.01.
Since we study multiple node centralities, each of which can predict
the given gene as aging-related, we score our predictions so that the more
centrality measures support a prediction and the higher the significance of
the change of its centrality values with age, the higher the score and the
more credible the prediction. For details, see Supplementary Section S1.7.
2.3.3 Validation of predicted aging-related genes
Statistical significance of our predictions. To test whether our approach
of combining static network data with aging-related expression data into
the dynamic network data actually gives meaningful predictions, we study
whether the number of aging-related genes that we predict from the actual
data is statistically significantly larger than the number of aging-related
genes that we predict from “randomized data”. By “randomized data”,
we mean that we randomize the expression data before integrating it with
the static network data (Supplementary Section S1.8). Then, we integrate
the randomized expression data with the static PPI network, construct
randomized age-specific networks just as in Section 2.1.3, and predict aging-
related genes from the randomized networks just as in Section 2.3.2. We
repeat the above procedure multiple times, in order to assign a p-value to the
number of predictions that we make from the actual data (Supplementary
Section S1.8).
Overlap between genes of different data sets. We measure the statistical
significance of the overlap of genes in one data set and genes in another data
set by using the hypergeometric test, which computes probability p (i.e., p-
value) of observing the same or larger overlap by chance as follows. Let E
denote the set of genes that are present in StatNetExpression. |E| = 6, 397.
Let A denote the subset of genes in E that are in any one of the two data
sets. Let G denote the subset of genes in E that are in the other data set. Let
O denote the set of genes that are in the overlap between A and G. Then, p
is: p = 1−
|O|−1∑
i=0
(|E|
i
)(|E|−|A|
|G|−i
)
(|E|
|G|
) . We use the p-value threshold of 0.05.
Gene Ontology (GO) enrichment. We study the enrichment of a data set
in biological process GO terms (Ashburner et al., 2000). We use: 1) all
4,913 GO terms that annotate (independent on the evidence code) at least
two genes from StatNetExpression and 2) 2,088 GO terms that annotate
(with respect to an experimental evidence code only) at least two genes from
StatNetExpression. For a GO term g, we compute the statistical significance
of its enrichment via the above hypergeometric test formula, where now E is
the set of genes from StatNetExpression that are annotated by any GO term,
A is the gene set in which we are measuring GO term enrichment, G is the
subset of genes from E that are annotated by GO term g, and O is the set
of genes in the overlap between A and G. We use the p-value threshold of
0.05.
GO term overlap. We measure the statistical significance of the overlap of
GO terms enriched in one data set and GO terms enriched in another data set
via the above hypergeometric test formula, where now E is the set of GO
terms that annotate at least two genes from StatNetExpression, A is the set
of GO terms enriched in any one of the two data sets, G is the set of GO
terms enriched in the other data set, and O is the set of GO terms that are in
the overlap between A and G. We use the p-value threshold of 0.05.
Disease Ontology (DO) enrichment. We study the enrichment of a data set
in all 517 DO terms that annotate at least two genes from StatNetExpression
(Du et al., 2009) in the same way as when we study GO term enrichments.
DO term overlap. We study the overlap of DO terms from different data sets
in the same way as when we study GO term overlaps.
Literature validation. We automatically search for a gene in PubMed
(http://www.pubmed.gov) and consider the gene to be validated in the
context of aging if its name is mentioned (according to NCBI’s E-utilities
– http://www.ncbi.nlm.nih.gov/books/NBK25500/) with “age”, “aging”, or
“ageing” in the title or abstract of at least one article. Also, we manually
search for a gene by reading relevant PubMed articles more closely.
3 RESULTS AND DISCUSSIONS
We study global topologies of the age-specific networks in Section
3.1. We study local topologies of proteins in each network and
predict aging-related genes in Sections 3.2.1 and 3.2.2. We validate
our predictions in Section 3.2.3.
3.1 Global network topologies do not change with age
3.1.1 Global properties of age-specific networks are similar
Average clustering coefficients, average diameters, and graphlet
frequency distributions (Section 2.2.1) of the age-specific networks
do not significantly change with age (Supplementary Fig. S1 and
S2).
3.1.2 Networks at different ages belong to the same graph family
We compare the fit of the age-specific networks to six network
models (Section 2.2.2). The best-fitting model does not change with
age (Supplementary Fig. S1 and S2). Note that our primary goal
is not to identify the best-fitting model for dynamic PPI networks.
Nonetheless, consistent to results for static PPI networks (Przˇulj
et al., 2010; Kuchaiev et al., 2011; Ratmann et al., 2009), it is gene
duplication models that fit the age-specific networks the best.
3.1.3 Overlap of age-specific networks is large The age-specific
networks share on average 93% of the nodes and 90% of the edges,
depending on age, while every pair of the networks shares at least
86% of the nodes and 79% of the edges (Supplementary Fig. S3).
Hence, the network overlaps are quite large.
3.2 Local topologies of proteins do change with age
3.2.1 Prediction of aging-related genes Gene expression data
alone revealed only 442 out of thousands of genes as aging-related
(Lu et al., 2004). Thus, while global network analysis failed to
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(a) (b) (c)
Fig. 2. The number of our predicted aging-related genes. Panel (a) shows the number of predictions for each of seven node centralities individually (BETWC,
CLOSEC, CLUSC, DEGC, ECC, GDC and KC) or by at least one of them (UNION). Panel (b) shows the number of genes predicted by exactly k
node centralities (k = 1, 2, . . . , 7). In the panels, blue and red bars show the number of genes that are positively and negatively correlated with age,
respectively. Green bars denote the number of genes for which one centrality measure identifies the given gene as positively correlated with age, while
another measure identifies the same gene as negatively correlated with age. Panel (c) shows the overlaps of our predictions with aging-related genes from
BrainExpression2008Age “ground truth” data, for each centrality individually or for all centralities combined. In the panel, blue and red bars show the number
of predicted genes that are absent from and present in the “ground truth” data, respectively. The p-values for the overlaps are noted at the top of the bars. The
results are consistent when we use Spearman correlation to predict aging-related genes instead of Pearson correlation (Section 2.3.2 and Supplementary Fig.
S4). Also, the results are consistent when we use BioGRID data as the static PPI network instead of HPRD data (Section 2.1.3 and Supplementary Fig. S5).
uncover any aging-related information, it could be that the dynamic
network data encodes aging-related information only locally and
around only a subset of nodes. So, we use node centrality measures
(Section 2.3.1) to quantify local positions of nodes in the age-
specific networks and find nodes whose centralities correlate well
with age, as such proteins could be key players in aging.
We predict a gene as aging-related if its centrality values are
statistically significantly correlated with age (Section 2.3.2) for at
least one centrality measure. This results in 515 (8.1%) predictions
out of all 6,397 genes. Fig. 2 (a) shows the number of aging-related
predictions for each centrality individually and all centralities
combined. No centrality predicts drastically more genes than others.
A gene’s centrality can be positively correlated with age (the gene
becomes more network-central with age) or it can be negatively
correlated with age (the gene becomes less central with age). The
majority of our predictions are negatively correlated with age (Fig.
2). This finding is encouraging, since it has already been argued that
aging is associated with failure of “hubs” – highly interconnected
and thus network-central proteins (Soltow et al., 2010).
3.2.2 Relationships and potential redundancies of different node
centralities We predict a gene as aging-related if its centrality
values correlate well with age with respect to at least one centrality.
So, we study whether any genes are predicted by more than one or
even all of the centralities. We find that almost half (43%) of the
515 aging-related predictions are supported by multiple centralities,
while the remaining predictions are supported by a single centrality
(Fig. 2 (b)). As expected, the number of predictions decreases as the
number of centralities supporting the predictions increases.
We study the redundancy of the different centralities by
computing, for each pair of centralities, the correlation between
their centrality values over all nodes in the given network, and
by averaging correlations over the 30 age-specific networks. We
observe high correlations between some measures, such as DEGC,
KC, and GDC, or CLOSEC and ECC (Fig. 3 (a) and Supplementary
Section S2.1). Thus, some centralities appear to be redundant to
others.
However, when we study pairwise overlaps of aging-related
predictions produced by the different centralities, the overlaps
are not very large for any pair of centralities (Fig. 3 (b)). This
result, together with the result from Fig. 2 (b), which shows that
the majority (∼57%) of the predictions are identified by a single
centrality, suggests that the centralities are not redundant to each
other. When we focus on our aging-related genes predicted by
exactly one centrality measure, in most cases, these predictions
are not even marginally significant with respect to other centrality
measures (Fig. 3(c) and Supplementary Fig. S6), indicating again
that the different centralities are in general not redundant to each
other. Thus, we keep all 515 predictions, independent on the number
of centralities supporting the given prediction. Henceforth, we
denote this set of 515 aging-related genes predicted via dynamic
network analysis as DyNetAge. We denote the complement of this
set, i.e., the set of genes that are present in StatNetExpression but not
in DyNetAge, as DyNetComplement. Clearly, DyNetComplement is
the set of genes whose centralities do not significantly correlate with
age, and as such, we do not predict them as aging-related.
Next, we study the effect of the number of centralities
supporting a prediction on the quality of the prediction. It is not
necessarily the case that predictions supported by many centralities
are more enriched in “ground truth” aging-related genes (see
below) compared to predictions supported by only few centralities
(Supplementary Fig. S7). Nonetheless, it is the case that the
more centralities support a prediction, the more significant the
correlation of its centrality values with age (as indicated by lower
p-values in Fig. 3(d)). Hence, to account for the number of
centralities supporting a prediction, we rank the prediction so that
the more centralities support it and the more significant the change
of its centrality values with age, the more credible the prediction
(Section 2.3.2). (Supplementary Tables S1 and S2 contain the
ranked lists of all predictions.) We validate our scoring scheme
by demonstrating that our 10% highest-scoring predictions are
statistically significantly enriched in genes that are present in more
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than one “ground truth” data set (p-value of 0.003), whereas this is
not the case for the lower-scoring predictions.
(a) (b)
(c) (d)
Fig. 3. Relationships between different centralities (BETWC, CLOSEC,
CLUSC, DEGC, ECC, GDC and KC): (a) Spearman correlation between
each pair of centralities averaged over the 30 age-specific networks;
(b) pairwise overlap of aging-related genes predicted by the different
centralities; (c) percentage of genes predicted as aging-related (p-value
≤ 0.01) by exactly one centrality (listed in a given row), which have a
“marginal” p-value between 0.01 and 0.05 with respect to one of the six
remaining centralities (listed in a given column), and (d) distributions of p-
values of our predicted aging-related genes. Panel (c) can be interpreted as
follows. For example, many of the predictions identified only by CLOSEC
(the second last row) are marginally significant with respect to DEGC,
ECC, GDC, and KC (intensive color), while almost none of the predictions
identified only by BETWC (the last row) are marginally significant with
respect to any other centrality (light color). Hence, the predictions made by
CLOSEC only may be more credible than the predictions made by BETWC
only, as the former are marginally supported by additional centralities, but
the latter are not.
3.2.3 Validation of predicted aging-related genes
Dynamic network analysis gives meaningful and statistically
significant aging-related predictions. The number of aging-
related genes in DyNetAge is statistically significantly larger than
the number of aging-related genes that we can predict from
the “randomized” data (Z-score= 7.42, p-value < 10−10;
Section 2.3.3).
Overlap of our predictions with “ground truth” aging-related
genes is statistically significant. Human aging is hard to study
experimentally due to long life span and ethical constraints. Instead,
human aging-related “ground truth” knowledge has been predicted
more or less computationally, by studying gene expression data
or by transferring aging-related knowledge from model species to
human via sequence comparison. (We intentionally use quotes,
as we are not dealing with true, experimentally obtained ground
truth data.) Similarly, here, we aim to computationally predict
new “ground truth” aging-related data from an additional data type
– PPIs. (But by no means do we claim to identify all aging-
related genes.) Hence, since “ground truth” data sets are predicted
computationally, they could be noisy. Also, different “ground
truth” sets could be biased towards different data types from which
the predictions have been made, be it expression, sequence, or
PPI data. Since different data types could be capturing different
functional slices of the cell (Memisˇevic´ et al., 2010; Przytycka
and Kim, 2010), it might not be alarming if the intersections
between the different “ground truth” sets are not very large.
However, since all the sets are aiming to capture the same biological
phenomenon (aging), some overlap would be encouraging. Ideally,
we would like to see a statistically significant overlap. However,
the existence of some overlap would be encouraging even if the
overlap was not significant, since: (1) the overlap could be low
due to the noisiness of each of the “ground truth” sets, and (2)
statistically non-significant results may be biologically important,
whereas statistically significant results may not be (Motulsky, 1995;
Milenkovic´ et al., 2010a; Ho et al., 2010).
We measure the overlap of DyNetAge with five “ground truth”
data sets: BrainExpression2004Age, BrainExpression2008Age,
ADExpressionAge, HGPSExpressionAge, and SequenceAge
(Section 2.1.4). Of the five, BrainExpression2004Age and
BrainExpression2008Age are the most likely to be similar to
DyNetAge (as all three are based on brain-related data, brain-
related gene expression data, and brain aging-related gene
expression data; Supplementary Section S2.2), followed by
ADExpressionAge (as our predictions as well as this data are
both based on brain-related data and brain-related gene expression
data), followed by HGPSExpressionAge (as our predictions as
well as this data are both based on gene expression data),
followed by SequenceAge (as our predictions and this data
both capture aging-related information but from different data
types) (Section 2.1.4). Therefore, a high overlap of DyNetAge
with BrainExpression2004Age or BrainExpression2008Age would
validate our method. A high overlap with ADExpressionAge would
suggest that our method could capture not only brain aging-related
genes but also brain aging-related disease genes. A high overlap
with HGPSExpressionAge would suggest that our method could
capture genes related to a tissue different from the brain tissue.
A high overlap with SequenceAge would suggest that our method
could capture genes identified from a different data type, namely
sequence data.
As hypothesized, DyNetAge overlaps the most (as indicated
by the lowest p-values) with BrainExpression2004Age and
BrainExpression2008Age, followed by ADExpressionAge, HGPSExpressionAge,
and SequenceAge, respectively (Supplementary Fig. S8 and
Supplementary Table S3). The overlap is statistically significant
for BrainExpression2004Age, BrainExpression2008Age, and
ADExpressionAge, marginally significant for HGPSExpressionAge,
and non-significant for SequenceAge (Table 1). The (marginally)
significant overlap between DyNetAge and four out of the
five “ground truth” data sets is encouraging. Importantly, even
though most of the overlaps are statistically significant, 87%,
31%, 74%, 87%, and 96% of our DyNetAge predictions
are not in BrainExpression2004Age, BrainExpression2008Age,
ADExpressionAge, HGPSExpressionAge, and SequenceAge,
respectively, and 19% of our predictions are not in any of the
five data sets (Supplementary Table S4). This confirms that data
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integration can reveal additional biological knowledge compared to
studying individual data types.
Some overlap between DyNetAge and SequenceAge is also
encouraging, even though the overlap is non-significant (as argued
above). Further, the overlap is stronger between DyNetAge and
the other four “ground truth” data sets (BrainExpression2004Age,
BrainExpression2008Age, ADExpressionAge, and HGPSExpressionAge)
than between SequenceAge and these four “ground truth” data
sets. In particular, whereas DyNetAge overlaps significantly with
three of the four data sets and marginally significantly with
respect to the fourth data set (see above), SequenceAge overlaps
significantly with just one of the four data sets (ADExpressionAge),
almost marginally significantly with respect to two of the four
data sets (HGPSExpressionAge and BrainExpression2004Age),
and non-significantly with respect to the remaining data set
(BrainExpression2008Age) (Supplementary Table S3). Therefore,
our DyNetAge appears to be more relevant than SequenceAge with
respect to the other “ground truth” data sets. The non-significant
overlaps could be due to potential complementarity of the different
types of biological data, noisiness of the “ground truth” data,
or some of the “ground truth” data sets being biased towards
brain-related genes.
Recall that the complement of each “ground truth” data set
(including DyNetAge) is the set of genes not predicted as aging-
related by the given study (Section 2.1.5). Hence, it would be
encouraging to see: 1) low (non-significant) overlaps between
DyNetAge and complements of the “ground truth” data sets, 2)
low (non-significant) overlaps between DyNetComplement and
“ground truth” sets, and 3) high (significant) overlaps between
DyNetComplement and complements of “ground truth” sets.
Indeed, this is what we typically observe in all three cases
(Supplementary Table S3).
Table 1. Overlap and its statistical significance (i.e. p-value) between
aging-related genes (ARG), GO terms (GO), and DO terms (DO)
in DyNetAge and those in the five “ground truth” aging-related
data sets (BrainExpression2004Age (BE4A), BrainExpression2008Age
(BE8A), ADExpressionAge (ADEA), HGPSExpressionAge (HEA), and
SequenceAge (SA)).
BE4A BE8A ADEA HEA SA
ARG Overlap 20% 69% 26% 13% 9%
p-value 5.5E-13 <1E-15 4.3E-7 0.06 0.39
GO Overlap 20% 21% 12% 6% 17%
p-value 1.2E-10 2.5E-14 2.8E-6 0.28 0.33
DO Overlap 25% 25% 0% 0% 25%
p-value 0.03 7.2E-3 N/A N/A 0.70
GO enrichment. When analyzing all gene-GO term associations,
146 GO terms are significantly enriched in DyNetAge (p-values
between 0.047 and 1.5 × 10−5), while only 14 GO terms are
enriched in DyNetComplement (p-values between 0.043 and 5.1×
10
−5) (Section 2.3.3). Importantly, there is no overlap between
the GO terms from DyNetAge and those from DyNetComplement.
Hence, our aging-related predictions group by functions that are
different than functions of genes that we do not predict as aging-
related.
When we focus on aging-related GO terms only, it is encouraging
that DyNetAge contains genes annotated with aging, cell aging,
and cellular senescence GO terms, as well as that DyNetAge’s
performance is typically comparable to that of the “ground truth”
data, especially when using only gene-GO term associations
obtained by experimental evidence codes (Supplementary Section
S2.3).
GO overlap. Our predictions are further validated by: 1) high
overlaps between GO terms from DyNetAge and GO terms
from the “ground truth” data sets, 2) low overlaps between
GO terms from DyNetAge and GO terms from complements
of the “ground truth” sets, 3) low overlaps between GO
terms from DyNetComplement and GO terms from the “ground
truth” sets, and 4) high overlaps between GO terms from
DyNetComplement and GO terms from complements of the
“ground truth” sets (Table 1 and Supplementary Table S5).
For example, when considering gene-GO term associations of
any evidence code, GO terms from DyNetAge significantly
overlap with GO terms from three of the five “ground truth”
data sets (BrainExpression2004Age, BrainExpression2008Age, and
ADExpressionAge), and some (though non-significant) overlap
with GO terms from HGPSExpressionAge and SequenceAge is
also encouraging (Table 1). Equivalent results when considering
gene-GO term associations of experimental evidence codes only
are shown in Supplementary Table S6. Importantly, in this case,
SequenceAge fails to significantly overlap with any other “ground
truth” set, whereas DyNetAge still significantly overlaps with
BrainExpression2008Age. For details, see Supplementary Section
S2.4.
DO enrichment. Eight diseases are significantly enriched in
DyNetAge (p-values between 0.041 and 6 × 10−3), while 14
diseases are enriched in DyNetComplement (p-values between
0.049 and 2.9 × 10−3) (Section 2.3.3). Importantly, there is
no overlap between diseases from DyNetAge and those from
DyNetComplement.
The eight diseases in DyNetAge are: brain disease, brain
tumor, bipolar disorder, connective tissue disease, renal tubular
acidosis, leukodystrophy, neuroblastoma, and demyelinating
disease. Brain disease and renal tubular acidosis are enriched
in SequenceAge as well, brain disease and bipolar disorder are
enriched in BrainExpression2004Age as well, and brain tumor
and neuroblastoma are enriched in BrainExpression2008Age as
well. All of these overlaps are encouraging. (We quantify the
significance of the overlaps in the following section.) In particular,
renal tubular acidosis, whose aging-related evidence is supported
by SequenceAge, is kidney-related, whereas DyNetAge has been
predicted from the brain-related data. Capturing this non-brain-
related disease in DyNetAge is encouraging, especially because
BrainExpression2004Age and BrainExpression2008Age fail to do
so. Further aging-related evidence for these five diseases can
be found in the following references denoted by their PubMed
IDs (PMIDs): 11256685, 8040891, 21197651, and 21031036.
Supplementary Table S7 maps PMIDs to full paper references.
Importantly, even three diseases from DyNetAge that are missed
by all “ground truth” sets can all be linked to aging in the literature
as well (Supplementary Section S2.5).
DO overlap. We further validate our predictions by demonstrating:
1) high overlaps between DO terms from DyNetAge and DO
terms from the “ground truth” data sets, 2) low overlaps between
DO terms from DyNetAge and DO terms from complements of
the “ground truth” sets, 3) low overlaps between DO terms from
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DyNetComplement and DO terms from the “groung truth” sets,
and 4) high overlaps between DO terms from DyNetComplement
and DO terms from complements of the “ground truth” sets
(Supplementary Table S8). For example, DO terms from DyNetAge
statistically significantly overlap with DO terms from two of
the five “ground truth” data sets (BrainExpression2004Age and
BrainExpression2008Age) (Table 1). It is not alarming that
DyNetAge does not significantly overlap with ADExpressionAge,
HGPSExpressionAge, or SequenceAge, since none of the three
overlaps significantly with more than one of the five “ground truth”
data sets (Supplementary Table S8). Hence, DyNetAge is better
supported by the “ground truth” data than any of these three data
sets. For details, see Supplementary Sections S2.6 and S2.7.
Literature validation. Automatic literature validation (Section
2.3.3) is prone to errors: we “validate” in this manner equal portion
of both the “ground truth” aging-related sets and their complements.
Therefore, we aim to validate our predictions manually (Section
2.3.3). Since manual validation is laborious, we focus on our
10% highest-scoring predictions (Section 2.3.2). Of these, we
study predictions that are absent from all “ground truth” sets,
namely DVL1, ACACA, HOMER3, GJB1, FKBP8, and H1F0.
We successfully validate all of these genes. DVL1 has been
linked to Alzheimer’s disease (PMID: 11803455), which has been
linked to aging itself (PMID: 21197651, 21031036). Expression
level of ACACA in rat changes with age (PMID: 11044254), and
so its human ortholog is an aging-related candidate. HOMER-
1A, a member of the same family as HOMER3, affects the
level of cognitive performance during aging (PMID: 23054826).
The expression of GJB1 is down-regulated with aging (PMID:
22337502). Drug targeting of FKBP38 might successfully intervene
with FKBP38-dependent processes such as programmed cell death
in cancer or neurodegenerative diseases (PMID: 21514222), which
have been linked to aging (PMID: 21197651, 21031036). H1F0 has
been linked to age-related macular degeneration (PMID: 16518403),
and its rat ortholog causes aging-related alterations in liver (PMID:
8114518).
4 CONCLUSION
Together, our results confirm that dynamic PPI network analysis
via integration of static PPI network data with aging-related gene
expression data can reveal meaningful key players in aging.
Funding: NSF EAGER CCF-1243295 grant.
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